IRIS Regtech Solutions Ltd
IRIS Regtech Solutions Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
IRIS has seen strong recent growth with a 25% YoY increase in total income and 36% YoY increase in EBITDA for FY '25. - The SupTech segment led growth with 34% YoY increase; TaxTech grew 20%, RegTech grew 12%. - Management expects substantial scaling of the SaaS business over the next 3-5 years, with growing recurring revenue (ARR approx. IRIS expects sustained growth driven by expansion in SupTech, TaxTech, and RegTech segments, with a strong focus on SaaS business scaling over the next 3 to 5 years.
From IRIS Regtech Solutions Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- IRIS has seen strong recent growth with a 25% YoY increase in total income and 36% YoY increase in EBITDA for FY '25.
- The SupTech segment led growth with 34% YoY increase; TaxTech grew 20%, RegTech grew 12%.
- Management expects substantial scaling of the SaaS business over the next 3-5 years, with growing recurring revenue (ARR approx. INR75 crores currently).
- Plans for calibrated but deliberate ramp-up in sales and marketing efforts, especially in North America and Europe.
- Cross-selling opportunities with 6,000+ customers exist but require prioritization based on urgency and client buying process.
- Growth less dependent on mandates in RegTech; focus shifting to deeper value-added sales in disclosure management and sustainability reporting.
2 more points from IRIS Regtech Solutions Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what IRIS Regtech Solutions Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is undertaking investments in product development, particularly in new products like accounts payable automation and TaxTech value-added services.
- The state-related initiative is at a pre-revenue stage; basic offerings are being developed and some current year spends will occur, with part of these costs capitalized (software development) and part expensed (community building).
- Capitalization policy: expenses related to new or mandate-driven product modules are capitalized, e.g., Malaysian e-invoicing module; other development expenses are expensed the same year.
2 more points from IRIS Regtech Solutions Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in IT - Software
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what IRIS Regtech Solutions Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company currently has a "good handful" of Request for Proposals (RFPs) in play, though an exact number is not disclosed.
- Some RFPs have been postponed, and certain bids, such as one from a Middle East regulator submitted in September, have not yet moved into the evaluation process.
- Recent order wins include two substantial RFPs: PFRDA in the previous year and Qatar Central Bank by the end of the financial year.
- The South African deal still has about 35% of the implementation left.
- The company is actively pursuing multiple other deals currently in the pipeline.
2 more points from IRIS Regtech Solutions Ltd's call on order book
Pro opens every point from 15K+ earnings calls
IRIS Regtech Solutions Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹39 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What IRIS Regtech Solutions's management said in earlier quarters
Others in IT - Software this season
- ASM Technologies (Q4 FY25)
Q4 FY24: ₹445.92 million . Key concall takeaways from ASM Technologies Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Quick Heal Technologies Ltd (Q4 FY25)
Q4 FY25 Revenue: ₹65.1 Cr, down from ₹80.0 Cr in Q4 FY24 (approx. Key concall takeaways from Quick Heal Technologies Ltd's Q4 FY25 earnings call — and how it…
- Olatech Solutions Ltd (Q4 FY25)
Current order book in hand: ₹35 crores (as of June 2025). Key concall takeaways from Olatech Solutions Ltd's Q4 FY25 earnings call — and how it ranks against…
- Birlasoft Ltd (Q4 FY25)
The company has a strong cash position with cash and cash equivalents growing 24% YoY to $259.5 million as of FY25 end. Key concall takeaways from Birlasoft…
Arthneeti Pro · Annual
IRIS Regtech Solutions Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were IRIS Regtech Solutions Ltd Q4 FY25 results?
IRIS has seen strong recent growth with a 25% YoY increase in total income and 36% YoY increase in EBITDA for FY '25. - The SupTech segment led growth with 34% YoY increase; TaxTech grew 20%, RegTech grew 12%. - Management expects substantial scaling of the SaaS business over the next 3-5 years, with growing recurring revenue (ARR approx. IRIS expects sustained growth driven by expansion in SupTech, TaxTech, and RegTech segments, with a strong focus on SaaS business scaling over the next 3 to 5 years.
What is IRIS Regtech Solutions Ltd share price analysis?
IRIS Regtech Solutions Ltd currently shows a neutral. The stock trades at a P/E of 4.4 with a market cap of ₹545 Cr. Investors should review the full earnings analysis for detailed insights.
Is IRIS Regtech Solutions Ltd planning capital expenditure?
The company is undertaking investments in product development, particularly in new products like accounts payable automation and TaxTech value-added services.
Keep IRIS Regtech Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.